Nektar Therapeutics

NKTRNASDAQ
$61.90
2.664.49%
Last update: Sep 30, 11:28 AM

Nektar Therapeutics Ownership & Insider Activity

Nektar Therapeutics (NKTR) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 10.6% of shares outstanding. Institutional investors hold 42.2%. Over the past 90 days, insiders made 2 sales worth $43K.

Shares Outstanding

34.143M

Shares Float

30.975M

Insider Shares Owned

3.608M

Insider % Owned

10.6%

Institutional Shares Held

14.418M

Institutional % Held

42.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

2

$43K total

Net Activity

Net Selling

Net Value (90d)

-$43K

Nektar Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →
DateInsiderTitleTypeSharesPriceValue
Aug 18, 2026Jonathan ZalevskyCHIEF R&D OFFICERSELL186.000$71.98$13K
Aug 18, 2026HOWARD ROBINPRESIDENT & CEOSELL418.000$71.98$30K